"Long before Hollywood was hashtagging Ozempic and politicians were weighing in on GLP-1's, Novo Nordisk was doing something unheard of in pharma. They were betting on people the world had largely written off. People who had largely written themselves off. They were investing in obesity medicine at a time when most doctors still saw obesity as a moral failing instead of a chronic medical condition. At a time when the market treated weight loss as an issue of vanity and regulators cringed at the word "treatment," Novo stuck their collective neck out. They poured billions into research and pushed to develop a molecule that could change the game for people living with obesity, with zero guarantee that payers would ever get on board.
They were the true forerunners. The lone voice in the wilderness, crying out, "Obesity is a disease, and it's time we treat it like one."
....."In today's climate, where cost and access dominate the conversation and newer therapies are coming in faster, stronger, and even slightly cheaper, I'm not sure Novo Nordisk or Lars will ever get the respect they deserve from the patient community. But the truth is simple. Without Novo Nordisk, and innovative risk-takers like Lars, there is no serious obesity medicine. There is no On The Pen.
So today, we salute you, Lars Fruergaard Jørgensen".
Læs hele artiklen: https://onthepen.substack.com/p/novo-nordisk-an-honest-assessment?utm_source=substack&publication_id=4808993&post_id=163761771&utm_medium=email&utm_content=share&utm_campaign=email-share&triggerShare=true&isFreemail=true&r=ndnqr&triedRedirect=true
They were the true forerunners. The lone voice in the wilderness, crying out, "Obesity is a disease, and it's time we treat it like one."
....."In today's climate, where cost and access dominate the conversation and newer therapies are coming in faster, stronger, and even slightly cheaper, I'm not sure Novo Nordisk or Lars will ever get the respect they deserve from the patient community. But the truth is simple. Without Novo Nordisk, and innovative risk-takers like Lars, there is no serious obesity medicine. There is no On The Pen.
So today, we salute you, Lars Fruergaard Jørgensen".
Læs hele artiklen: https://onthepen.substack.com/p/novo-nordisk-an-honest-assessment?utm_source=substack&publication_id=4808993&post_id=163761771&utm_medium=email&utm_content=share&utm_campaign=email-share&triggerShare=true&isFreemail=true&r=ndnqr&triedRedirect=true
Overspiller Lars Rebien Sørensen sine kort?
Reel har han vel sagt at Novos bestyrelse er ikke deres penge værd.
Reel har han vel sagt at Novos bestyrelse er ikke deres penge værd.
